ENCOMPASS HEALTH CORP (EHC)
US29261A1007 - Common Stock
| MRQ (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 134.40M | 69.10M | 21.80M | 54.80M | 224.00M | |||
| Receivables | 619.30M | 611.60M | 536.80M | 680.30M | 572.80M | |||
| Other Current Assets | 176.10M | 161.10M | 158.60M | 186.30M | 151.80M | |||
| Total Current Assets | 929.80M | 841.80M | 717.20M | 921.40M | 948.60M | |||
| Non-Current Assets | ||||||||
| PPE Net | 3.57B | 3.51B | 3.15B | 2.84B | 2.45B | |||
| Investments And Advances | N/A | N/A | N/A | 4.00M | 5.50M | |||
| Goodwill | 1.28B | 1.28B | 1.26B | 2.43B | 2.32B | |||
| Intangibles | 272.20M | 278.20M | 282.30M | 417.50M | 431.30M | |||
| Other Non-Current Assets | 178.70M | 191.60M | 222.10M | 250.50M | 165.70M | |||
| Total Non-Current Assets | 5.30B | 5.26B | 4.92B | 5.94B | 5.50B | |||
| TOTAL ASSETS | 6.23B | 6.10B | 5.64B | 6.86B | 6.45B | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 25.60M | 24.80M | 25.20M | 42.80M | 38.30M | |||
| Accrued Expenses | 25.40M | 274.20M | 236.70M | 348.70M | 345.70M | |||
| Accounts Payable | 166.10M | 170.00M | 132.90M | 137.60M | 115.00M | |||
| Other Current Liabilities | 463.20M | 187.40M | 181.10M | 219.70M | 218.30M | |||
| Total Current Liabilities | 680.30M | 656.40M | 575.90M | 748.80M | 717.30M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 2.68B | 2.69B | 2.74B | 3.24B | 3.25B | |||
| Deferred Taxes/Income | 93.50M | 87.00M | 83.00M | 86.70M | 51.80M | |||
| Other Non-Current Liabilities | 371.60M | 374.00M | 373.90M | 386.30M | 424.60M | |||
| Total Non-Current Liabilities | 3.81B | 3.80B | 3.75B | 4.20B | 4.14B | |||
| TOTAL LIABILITIES | 4.49B | 4.45B | 4.33B | 4.95B | 4.86B | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | 503.70M | 406.50M | 115.70M | 141.80M | -242.30M | |||
| Additional Paid In Capital | 1.80B | 1.79B | 1.73B | 2.29B | 2.33B | |||
| Minority Interest | 635.20M | 538.70M | 458.00M | 384.70M | 330.30M | |||
| Common Shares | 1.20M | 1.20M | 1.10M | 1.10M | 1.10M | |||
| Treasury Stock | -560.20M | -547.20M | -536.70M | -521.20M | -497.40M | |||
| Other Shareholders' Equity | N/A | N/A | N/A | 487.90M | N/A | |||
| Shares Outstanding | 100.69M | 100.25M | 99.80M | 99.50M | 99.40M | |||
| Tangible Book Value per Share | 1.87 | 0.88 | -2.36 | -9.39 | -11.69 | |||
| Total Shareholders' Equity | 1.74B | 1.65B | 1.31B | 1.91B | 1.59B | |||
| TOTAL LIABILITIES AND EQUITY | 6.23B | 6.10B | 5.64B | 6.86B | 6.45B | |||
| Statistics | ||||||||
| Debt/Equity | 1.54 | 1.63 | 2.09 | 1.70 | 2.05 | |||
| Current Ratio | 1.37 | 1.28 | 1.25 | 1.23 | 1.32 | |||
| Return On Assets (ROA) | 6.01% | 5.73% | 4.79% | 5.98% | 4.39% | |||
| Return On Equity (ROE) | 21.48% | 21.22% | 20.59% | 21.47% | 17.83% | |||
| Return On Invested Capital (ROIC) | 10.69% | 10.48% | 9.71% | 8.41% | 7.22% | |||
| Return On Invested Capital Ex Cash (ROICexc) | 10.96% | 10.62% | 9.76% | 8.49% | 7.52% | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | 15.36% | 14.95% | 14.07% | 16.00% | 15.02% | |||
All data in USD